GENT.OL
Price:
$57
Market Cap:
$879.08M
Gentian Diagnostics ASA researches, develops, and produces biochemical reagents for use in medical diagnostics and research in Europe, Asia, and the United States. It offers in-vitro diagnostic reagents for clinical chemistry analyzers. The company's products include the gentian calprotectin immunoassay, a turbidimetric assay used for the measurement of calprotectin in plasma and serum for detection and assessment of inflammation; Cystatin C, a superior GFR marker for the diagnosis and therapeutic control of renal function; NT-proBNP Immunoassay for diagnosis, monitoring, and assessment of severity in individuals suspected of having congestive heart failure; and Canine c-reactive protein (CR...[Read more]
Industry
Medical - Devices
IPO Date
2016-12-14
Stock Exchange
OSL
Ticker
GENT.OL
According to Gentian Diagnostics ASA’s latest financial reports and current stock price. The company's current PE Ratio is 18.45. This represents a change of -40.75% compared to the average of 31.14 of the last 4 quarters.
The mean historical PE Ratio of Gentian Diagnostics ASA over the last ten years is -43.14. The current 18.45 PE Ratio has changed -4376.29% with respect to the historical average. Over the past ten years (40 quarters), GENT.OL's PE Ratio was at its highest in in the June 2017 quarter at 382.18. The PE Ratio was at its lowest in in the September 2018 quarter at -387.50.
Average
-43.14
Median
-44.54
Minimum
-89.88
Maximum
13.35
Discovering the peaks and valleys of Gentian Diagnostics ASA PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 128.16%
Maximum Annual PE Ratio = 13.35
Minimum Annual Increase = -122.21%
Minimum Annual PE Ratio = -89.88
Year | PE Ratio | Change |
---|---|---|
2024 | 13.35 | -122.21% |
2023 | -60.11 | 128.16% |
2022 | -26.34 | -41.15% |
2021 | -44.76 | -8.79% |
2020 | -49.08 | 103.53% |
2019 | -24.11 | -45.60% |
2018 | -44.33 | 10.70% |
2017 | -40.04 | -39.45% |
2016 | -66.13 | -26.42% |
2015 | -89.88 | -9.73% |
The current PE Ratio of Gentian Diagnostics ASA (GENT.OL) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-24.37
5-year avg
-33.39
10-year avg
-43.14
Gentian Diagnostics ASA’s PE Ratio is less than Nordic Nanovector ASA (0), greater than Ultimovacs ASA (-0.35), greater than BerGenBio ASA (-0.49), less than Photocure ASA (2.02K), greater than Goodtech ASA (-10.95),
Company | PE Ratio | Market cap |
---|---|---|
0 | $451.20M | |
-0.35 | $70.53M | |
-0.49 | $68.79M | |
2.02K | $1.34B | |
-10.95 | $277.82M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Gentian Diagnostics ASA using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Gentian Diagnostics ASA or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Gentian Diagnostics ASA's PE Ratio?
How is the PE Ratio calculated for Gentian Diagnostics ASA (GENT.OL)?
What is the highest PE Ratio for Gentian Diagnostics ASA (GENT.OL)?
What is the 3-year average PE Ratio for Gentian Diagnostics ASA (GENT.OL)?
What is the 5-year average PE Ratio for Gentian Diagnostics ASA (GENT.OL)?
How does the current PE Ratio for Gentian Diagnostics ASA (GENT.OL) compare to its historical average?